REQUEST A DEMO
Total
USD $0.00
Search more companies

YH Bio Co.,Ltd. (Taiwan, China)

Main Activities: Professional, Scientific, and Technical Services
Full name: YH Bio Co.,Ltd. Profile Updated: September 23, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Vita Genomics, Inc., founded in March 2001, has established its headquarter in Taiwan, a marketing office in California, USA, and a wholly owned subsidiary GeneCore in Shanghai, China. The company focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields.

Headquarters
7Fl., No.6, Sec.1, Jungshing Rd., Wugu Shiang
New Taipei City; New Taipei City;

Contact Details: Purchase the YH Bio Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the YH Bio Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the YH Bio Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the YH Bio Co.,Ltd. report to view the information.
Incorporation Date:
March 09, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
12.71%
Purchase this report to view the information.
6.7%
Purchase this report to view the information.
6.28%
Purchase this report to view the information.
2.11%
Subsidiaries
亞桐投資有限公司
100%
豐源生生技股份有限公司
51%
Company Performance
Financial values in the chart are available after YH Bio Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
9194.71%
Total assets
5.71%
Total equity
5.86%
Return on Equity (ROE)
4.09%
Quick Ratio
5.71%
Cash Ratio
-12.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?